CELH
Celsius Holdings, Inc.
CELH has the edge over CLX overall, supported by stronger modeled upside and stronger fundamentals.
CLX
The Clorox Company
CLX offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CLX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Weak |
CLX's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is weak.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
CLX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $108 | -0.3% |
| Forward | 19x | $108 | — |
| Current | 20x | $108 | — |
| Fair | 34x | $187 | +73% |
| Expensive | 73x | $403 | +273% |
Historical ranges are pointers, not guarantees.
CLX has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over CLX on the outlook, with more favorable valuation and earnings expectations.
CLX Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Growth | |
| Weakening | |
| Moderate | |
| Low |
Analysts expect CLX's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
CLX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.73 | +3.2% |
| Q3 2026 | $5.55 | -13% |
| Q2 2026 | $4.81 | -26% |
| Q1 2026 | $6.16 | +10% |
| Q4 2025 | $6.12 | +67% |
| Q3 2025 | $6.37 | +121% |
| Q2 2025 | $6.52 | +190% |
| Q1 2025 | $5.58 | +188% |
| Q4 2024 | $3.67 | +473% |
CLX has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over CLX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over CLX on profitability, with a higher operating margin.
CLX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +33% |
| Q2 2026 | $1.9B | -2% |
| Q1 2026 | $1.7B | +0.1% |
| Q4 2025 | $1.7B | -0.8% |
| Q3 2025 | $1.4B | -19% |
| Q2 2025 | $2B | +4.5% |
| Q1 2025 | $1.7B | -8% |
| Q4 2024 | $1.7B | -15% |
CLX's revenue is growing: $1.9B last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.4 points |
| Q2 2026 | 11% | -9.7 points |
| Q1 2026 | 15% | +0.1 points |
| Q4 2025 | 13% | -1.2 points |
| Q3 2025 | 7.5% | -2.6 points |
| Q2 2025 | 21% | +6.2 points |
| Q1 2025 | 15% | +18 points |
| Q4 2024 | 14% | +7.2 points |
CLX's operating margin was 11% last quarter, up 3.4 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
CLX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $105M | +84% |
| Q2 2026 | $244M | +11% |
| Q1 2026 | -$165M | -171% |
| Q4 2025 | $269M | +112% |
| Q3 2025 | $57M | -69% |
| Q2 2025 | $219M | -15% |
| Q1 2025 | $233M | +83% |
| Q4 2024 | $127M | +26% |
CLX has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over CLX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
CLX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -105K shares |
| 1 year | -0.8% | -991K shares |
| 3 years | -2.1% | -2.6M shares |
| 5 years | -1.6% | -2M shares |
| Available history | -3.8% | -4.9M shares |
CLX has 122M diluted shares, down 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $127M |
| Q3 2025 | $129M |
| Q2 2025 | $75M |
| Q1 2025 | — |
| Q4 2024 | $150M |
CLX spent $127M buying back its own shares over the past year, down 64% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over CLX on leverage, with a lower net debt burden relative to earnings.
CLX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.3x | High |
| Q2 2026 | 4.7x | High |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 2.0x | Healthy |
| Q4 2024 | 2.7x | Moderate |
CLX's net debt is about 4.3 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
CLX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 64.3 | Neutral |
CLX's weekly RSI is 62 (neutral) and its Stochastic is 64 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
CLX PE vs Consumer Defensive Sector
| Metric | CLX | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 19x | 0.1% above |
| PE % | 17 | 18 | 1 pt below |
CLX has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
CLX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $89.7 | 21% above |
| 20 week MA | $94.1 | 15% above |
| 50 week MA | $100.2 | 8% above |
| 100 week MA | $116.9 | 7.5% below |
| 200 week MA | $133.4 | 19% below |
CLX has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
CLX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $153.5 | $203.8 | +33% |
| 2021 | $203.8 | $169.8 | -17% |
| 2022 | $169.8 | $144.1 | -15% |
| 2023 | $144.1 | $142.6 | -1.1% |
| 2024 | $142.6 | $163.0 | +14% |
| 2025 | $163.0 | $98.5 | -40% |
| 2026 YTD | $98.5 | $108.2 | +9.8% |
CLX has the edge over CELH on returns for 2026, with the stronger performance.